PHS
ILMN icon

PFM Health Sciences’s Illumina ILMN Stock Holding History

PFM Health Sciences’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-572,802
Closed -$71.3M – 109
2016
Q4 		$71.3M Buy
+572,802
New +$77.2M 2.01% 19

Other funds holding ILMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PFM Health Sciences's ILMN Position: Q2 2026 in Review

PFM Health Sciences increased its Illumina (ILMN) stake by 21% in Q2 2026, buying an estimated $903K and bringing the position to 35,040 shares worth $6.16M. The position accounts for 0.53% of the portfolio, ranked #60.

PFM Health Sciences first reported a position in ILMN in Q4 2013 and has held it in 6 quarters since. The position peaked at $69.6M in Q1 2015. 937 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • PFM Health Sciences held 35,040 shares of Illumina worth $6.16M as of Q2 2026.
  • PFM Health Sciences bought 6,171 Illumina shares in Q2 2026, an estimated $903K.
  • Illumina made up 0.53% of PFM Health Sciences's portfolio in Q2 2026, its #60 holding.
  • PFM Health Sciences first reported a position in Illumina in Q4 2013 and has held it in 6 quarters since.
  • PFM Health Sciences's Illumina position peaked at $69.6M in Q1 2015.
  • 937 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.